STOCK TITAN

Cibus (CLXT) Stock News, Oct 13-29, 2020

CLXT NASDAQ
Rhea-AI Summary

Calyxt, Inc. (NASDAQ: CLXT) announced an exclusive licensing agreement with S&W Seed Company for an improved quality alfalfa seed in the U.S. This marks Calyxt's first commercial trait license agreement, with potential revenues exceeding $10 million based on U.S. sales projections. The new alfalfa, branded as IQ Alfalfa, aims to enhance livestock performance through improved digestibility and quality. Field trials are planned for 2021, and S&W Seed Company will support research on yield and animal performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.14%
Tags
none
-
Rhea-AI Summary

Calyxt, Inc. (NASDAQ: CLXT) will host a Virtual Analyst Day on November 17, 2020, at 4:00 p.m. Eastern time. This event will feature an overview of the company’s research and development pipeline and a business update from management, followed by a Q&A session with analysts. The event can be accessed via a webcast link provided in the announcement. A replay will be available post-event until December 1, 2020. For further inquiries, contact the investor relations team.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
conferences
-
Rhea-AI Summary

Calyxt, a plant-based technology company, has completed a registered direct offering of 3,750,000 shares of common stock, priced at $4.00 per share, totaling gross proceeds of $15 million. Cellectis S.A., the majority shareholder, purchased 1,250,000 shares. The funds will be used for general corporate purposes, advancing product development and TALEN® technology. The offering was conducted under an effective registration statement with the SEC, utilizing a prospectus filed on October 16, 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
Rhea-AI Summary

Calyxt, Inc. (NASDAQ: CLXT) announced a registered direct offering of 3,750,000 shares at $4.00 per share, expected to close on October 20, 2020. Majority shareholder Cellectis S.A. will purchase 1,250,000 shares. The gross proceeds are projected at $15 million, aimed at advancing product development and enhancing TALEN® technology. H.C. Wainwright & Co. serves as the exclusive placement agent. This offering is facilitated under an effective shelf registration statement with the SEC, and a final prospectus will be available on the SEC website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.27%
Tags
-
Rhea-AI Summary

Calyxt, Inc. (NASDAQ: CLXT) has appointed Sarah Reiter as Vice President of Business Development. With over 25 years of experience in agribusiness, Ms. Reiter aims to enhance Calyxt's go-to-market strategies by leveraging her expertise in international business development and partnerships. Previously, she served as Chief Commercial Officer at Arcadia Biosciences, leading global commercialization efforts. This strategic hire is expected to strengthen Calyxt's market position in plant-based innovations amidst growing consumer demand.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.79%
Tags
management
-
Rhea-AI Summary

Calyxt, Inc. (NASDAQ: CLXT) will hold a conference call on November 5, 2020, at 4:30 p.m. EST to discuss its Q3 2020 results, with a press release to be issued beforehand. CEO Jim Blome and CFO Bill Koschak will lead the call, which will include a Q&A session. Interested parties can access the conference via 1-877-407-0789 for US callers or 1-201-689-8562 for international callers. The call will be live-streamed and available for replay. For further information, visit Calyxt's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.68%
Tags
conferences earnings date